• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在病毒竞争实验中估计相对适应性。

Estimating relative fitness in viral competition experiments.

作者信息

Marée A F, Keulen W, Boucher C A, De Boer R J

机构信息

Theoretical Biology, Utrecht University, Utrecht, The Netherlands.

出版信息

J Virol. 2000 Dec;74(23):11067-72. doi: 10.1128/jvi.74.23.11067-11072.2000.

DOI:10.1128/jvi.74.23.11067-11072.2000
PMID:11070001
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC113186/
Abstract

The relative fitness of viral variants has previously been defined as the slope of the logarithmic ratio of the genotype or phenotype frequencies in time plots of pairwise competition experiments. Developing mathematical models for such experiments by employing the conventional coefficient of selection s, we demonstrate that this logarithmic ratio gives the fitness difference, rather than the relative fitness. This fitness difference remains proportional to the actual replication rate realized in the particular experimental setup and hence cannot be extrapolated to other situations. Conversely, the conventional relative fitness (1 + s) should be more generic. We develop an approach to compute the generic relative fitness in conventional competition experiments. This involves an estimation of the total viral replication during the experiment and requires an estimate of the average lifetime of productively infected cells. The novel approach is illustrated by estimating the relative fitness, i.e., the relative replication rate, of a set of zidovudine-resistant human immunodeficiency virus type 1 variants. A tool for calculating the relative fitness from observed changes in viral load and genotype (or phenotype) frequencies is publically available on the website at http://www-binf.bio.uu.nl/( approximately )rdb/fitness.html.

摘要

病毒变体的相对适应性先前被定义为成对竞争实验时间图中基因型或表型频率对数比的斜率。通过使用传统的选择系数s为此类实验建立数学模型,我们证明这种对数比给出的是适应性差异,而非相对适应性。这种适应性差异仍然与在特定实验设置中实现的实际复制率成比例,因此不能外推到其他情况。相反,传统的相对适应性(1 + s)应该更具通用性。我们开发了一种在传统竞争实验中计算通用相对适应性的方法。这涉及估计实验期间的病毒总复制量,并且需要估计有效感染细胞的平均寿命。通过估计一组齐多夫定耐药的1型人类免疫缺陷病毒变体的相对适应性,即相对复制率,来说明这种新方法。可在网站http://www-binf.bio.uu.nl/( approximately )rdb/fitness.html上公开获取一个根据观察到的病毒载量和基因型(或表型)频率变化来计算相对适应性的工具。

相似文献

1
Estimating relative fitness in viral competition experiments.在病毒竞争实验中估计相对适应性。
J Virol. 2000 Dec;74(23):11067-72. doi: 10.1128/jvi.74.23.11067-11072.2000.
2
Modeling and estimation of replication fitness of human immunodeficiency virus type 1 in vitro experiments by using a growth competition assay.通过生长竞争试验对1型人类免疫缺陷病毒体外实验中的复制适应性进行建模和估计。
J Virol. 2006 Mar;80(5):2380-9. doi: 10.1128/JVI.80.5.2380-2389.2006.
3
Factors affecting relative fitness measurements in pairwise competition assays of human immunodeficiency viruses.影响人类免疫缺陷病毒成对竞争分析中相对适合度测量的因素。
J Virol Methods. 2013 Dec;194(1-2):7-13. doi: 10.1016/j.jviromet.2013.07.062. Epub 2013 Aug 8.
4
Pairwise growth competition assay for determining the replication fitness of human immunodeficiency viruses.用于确定人类免疫缺陷病毒复制适应性的成对生长竞争试验。
J Vis Exp. 2015 May 4(99):e52610. doi: 10.3791/52610.
5
Methods to determine HIV-1 ex vivo fitness.测定HIV-1体外适应性的方法。
Methods Mol Biol. 2005;304:355-68. doi: 10.1385/1-59259-907-9:355.
6
Procedures for reliable estimation of viral fitness from time-series data.从时间序列数据可靠估计病毒适应性的方法。
Proc Biol Sci. 2002 Sep 22;269(1503):1887-93. doi: 10.1098/rspb.2002.2097.
7
vFitness: a web-based computing tool for improving estimation of in vitro HIV-1 fitness experiments.vFitness:一个基于网络的计算工具,用于改进 HIV-1 体外适应度实验的估计。
BMC Bioinformatics. 2010 May 18;11:261. doi: 10.1186/1471-2105-11-261.
8
Notwithstanding Circumstantial Alibis, Cytotoxic T Cells Can Be Major Killers of HIV-1-Infected Cells.尽管存在间接不在场证明,但细胞毒性T细胞可能是HIV-1感染细胞的主要杀手。
J Virol. 2016 Jul 27;90(16):7066-7083. doi: 10.1128/JVI.00306-16. Print 2016 Aug 15.
9
Quantifying relative within-host replication fitness in influenza virus competition experiments.在流感病毒竞争实验中量化宿主内相对复制适应性
J Theor Biol. 2015 Oct 7;382:259-71. doi: 10.1016/j.jtbi.2015.07.003. Epub 2015 Jul 15.
10
Modeling and estimation of kinetic parameters and replicative fitness of HIV-1 from flow-cytometry-based growth competition experiments.基于流式细胞术的生长竞争实验对HIV-1动力学参数和复制适应性的建模与估计
Bull Math Biol. 2008 Aug;70(6):1749-71. doi: 10.1007/s11538-008-9323-4. Epub 2008 Jul 22.

引用本文的文献

1
Quantifying the strength of viral fitness trade-offs between hosts: a meta-analysis of pleiotropic fitness effects.量化宿主间病毒适应性权衡的强度:多效性适应性效应的荟萃分析。
Evol Lett. 2024 Jul 29;8(6):851-865. doi: 10.1093/evlett/qrae038. eCollection 2024 Dec.
2
Estimation of SARS-CoV-2 fitness gains from genomic surveillance data without prior lineage classification.基于基因组监测数据估计 SARS-CoV-2 的适应度增益,无需事先进行谱系分类。
Proc Natl Acad Sci U S A. 2024 Jun 18;121(25):e2314262121. doi: 10.1073/pnas.2314262121. Epub 2024 Jun 11.
3
RNA cis-regulators are important for Streptococcus pneumoniae in vivo success.RNA 顺式调控因子对肺炎链球菌在体内的成功至关重要。
PLoS Genet. 2024 Mar 5;20(3):e1011188. doi: 10.1371/journal.pgen.1011188. eCollection 2024 Mar.
4
HIV-1 usurps transcription start site heterogeneity of host RNA polymerase II to maximize replication fitness.HIV-1 利用宿主 RNA 聚合酶 II 的转录起始位点异质性来最大限度地提高复制适应性。
Proc Natl Acad Sci U S A. 2023 Jun 6;120(23):e2305103120. doi: 10.1073/pnas.2305103120. Epub 2023 May 30.
5
Genotype-phenotype landscapes for immune-pathogen coevolution.免疫病原体协同进化的基因型-表型景观。
Trends Immunol. 2023 May;44(5):384-396. doi: 10.1016/j.it.2023.03.006. Epub 2023 Apr 4.
6
Rift Valley fever virus detection in susceptible hosts with special emphasis in insects.裂谷热病毒在易感宿主中的检测,特别强调昆虫媒介。
Sci Rep. 2021 May 10;11(1):9822. doi: 10.1038/s41598-021-89226-z.
7
Pre-existing resistance in the latent reservoir can compromise VRC01 therapy during chronic HIV-1 infection.潜伏储库中预先存在的耐药性可能会影响慢性 HIV-1 感染期间的 VRC01 治疗效果。
PLoS Comput Biol. 2020 Nov 30;16(11):e1008434. doi: 10.1371/journal.pcbi.1008434. eCollection 2020 Nov.
8
Transposon Insertion Sequencing, a Global Measure of Gene Function.转座子插入测序,一种全面的基因功能测量方法。
Annu Rev Genet. 2020 Nov 23;54:337-365. doi: 10.1146/annurev-genet-112618-043838. Epub 2020 Sep 4.
9
Accumulated mutations by 6 months of infection collectively render transmitted/founder HIV-1 significantly less fit.在感染 6 个月时累积的突变使传播/原始 HIV-1 显著适应性降低。
J Infect. 2020 Feb;80(2):210-218. doi: 10.1016/j.jinf.2019.12.001. Epub 2019 Dec 5.
10
Mutational load causes stochastic evolutionary outcomes in acute RNA viral infection.突变负荷在急性RNA病毒感染中导致随机的进化结果。
Virus Evol. 2019 Apr 22;5(1):vez008. doi: 10.1093/ve/vez008. eCollection 2019 Jan.

本文引用的文献

1
Low dynamic state of viral competition in a chronic avian hepadnavirus infection.慢性禽嗜肝DNA病毒感染中病毒竞争的低动态状态
J Virol. 2000 Jun;74(11):5257-65. doi: 10.1128/jvi.74.11.5257-5265.2000.
2
Viral dynamics of acute HIV-1 infection.急性HIV-1感染的病毒动力学
J Exp Med. 1999 Sep 20;190(6):841-50. doi: 10.1084/jem.190.6.841.
3
Effect of population patchiness and migration rates on the adaptation and divergence of vesicular stomatitis virus quasispecies populations.种群斑块性和迁移率对水疱性口炎病毒准种群体适应性和分化的影响。
J Gen Virol. 1999 Aug;80 ( Pt 8):2051-2059. doi: 10.1099/0022-1317-80-8-2051.
4
HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment. Comet Study Group.高效抗逆转录病毒治疗中断期间的HIV-1反弹对重新开始治疗没有有害影响。彗星研究小组。
AIDS. 1999 Apr 16;13(6):677-83. doi: 10.1097/00002030-199904160-00008.
5
In vivo HIV-1 replicative capacity in early and advanced infection.
AIDS. 1999 Jan 14;13(1):67-73. doi: 10.1097/00002030-199901140-00009.
6
An RNA virus can adapt to the multiplicity of infection.RNA病毒能够适应感染复数。
J Gen Virol. 1998 Dec;79 ( Pt 12):2971-80. doi: 10.1099/0022-1317-79-12-2971.
7
Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy.丙型肝炎病毒的体内动态及α干扰素治疗的抗病毒疗效。
Science. 1998 Oct 2;282(5386):103-7. doi: 10.1126/science.282.5386.103.
8
Altered drug sensitivity, fitness, and evolution of human immunodeficiency virus type 1 with pol gene mutations conferring multi-dideoxynucleoside resistance.具有赋予多双脱氧核苷抗性的 pol 基因突变的 1 型人类免疫缺陷病毒的药物敏感性改变、适应性及进化。
J Infect Dis. 1998 May;177(5):1207-13. doi: 10.1086/515282.
9
Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro.齐多夫定耐药的1型人类免疫缺陷病毒分离株在体外的相对复制适应性
J Virol. 1998 May;72(5):3773-8. doi: 10.1128/JVI.72.5.3773-3778.1998.
10
HIV-1 directly kills CD4+ T cells by a Fas-independent mechanism.HIV-1通过一种不依赖Fas的机制直接杀死CD4+ T细胞。
J Exp Med. 1998 Apr 6;187(7):1113-22. doi: 10.1084/jem.187.7.1113.